Literature DB >> 12424695

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.

Bruce F Sabath1, Eugene O Major.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder of the human brain caused by infection with the human polyomavirus, JC. Up to 80% of humans express serum antibodies to JC virus (JCV), yet considerably fewer people develop PML-predominantly those under immunosuppressive conditions. Recent research showed JCV infection in multiple tissues throughout the body, suggesting sites for viral latency. These observations allow the proposal of pathways that JCV may use from sites of initial infection to the brain. Results from investigations into cell-surface receptors, intracellular DNA-binding proteins, and variant viral regulatory regions also suggest mechanisms that may regulate cellular susceptibility to JCV infection. Together, these data elucidate how JCV may establish infection in various cell types, persist latently or become reactivated, and ultimately reach the brain to cause PML.

Entities:  

Mesh:

Year:  2002        PMID: 12424695     DOI: 10.1086/344280

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

Review 1.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Progressive multifocal leukoencephalopathy in a patient with multiple myeloma.

Authors:  Masaru Akiyama; Toru Takahashi; Sinjo Nomura; Yoshimi Yamashita; Katsuhiro Hatao
Journal:  Int J Hematol       Date:  2010-05-28       Impact factor: 2.490

3.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Ozgür Yaldizli; Norman Putzki
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

4.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Authors:  Serena Delbue; Emanuela Branchetti; Renzo Boldorini; Luca Vago; Pietro Zerbi; Claudia Veggiani; Sara Tremolada; Pasquale Ferrante
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

5.  Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination?

Authors:  Carlo Visco; Enrico Marchioni; Fabrizio Pomponi; Pasquale Ferrante; Serena Delbue; Gianpietro Pellizzer; Francesco Rodeghiero
Journal:  Ann Hematol       Date:  2008-08-12       Impact factor: 3.673

6.  Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Authors:  E Iacobaeus; C Ryschkewitsch; M Gravell; M Khademi; E Wallstrom; T Olsson; L Brundin; Eo Major
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

7.  A 41-year-old female with progressive multifocal leukoencephalopathy after liver transplant.

Authors:  Zahra Ahmadinejad; Fatemeh Talebi; Niloofar Ayoobi Yazdi; Fereshteh Ghiasvand
Journal:  J Neurovirol       Date:  2019-05-28       Impact factor: 2.643

Review 8.  Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges.

Authors:  Paulo Fontoura
Journal:  MAbs       Date:  2010 Nov-Dec       Impact factor: 5.857

Review 9.  Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.

Authors:  Mark S Igra; David Paling; Mike P Wattjes; Daniel J A Connolly; Nigel Hoggard
Journal:  Br J Radiol       Date:  2017-04-26       Impact factor: 3.039

Review 10.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.